Goodman, L., Moeller, M., Guthrie, A., Earl, M., Pennel, N. and Gilligan, T. (2017) The Morbidity and Mortality Conference (MMC) in Oncology: A Patient Safety and root Cause Analysis (RCA)-Driven Approach at the Cleveland Clinic Taussig Cancer Institute (TCI). Journal of Clinical Oncology, 32, 191-191.
https://doi.org/10.1200/jco.2014.32.30_suppl.191

has been cited by the following article:

• TITLE: Hospital Admission Less than 30 Days after Chemotherapy: Results from a Chemotherapy-Specific Morbidity and Mortality Conference in Gynecologic Oncology

  AUTHORS: Lauren Philp, Tracilyn Hall, Lisa Diver, Annekathryn Goodman

  KEYWORDS: Gynecologic Oncology, Quality Improvement, Chemotherapy

  JOURNAL NAME: Journal of Cancer Therapy, Vol.11 No.6, June 28, 2020

  ABSTRACT: Introduction: Morbidity and Mortality (M&M) rounds can identify adverse events and improve patient safety however adoption in cancer centers is not routine. Herein we report the results of a chemotherapy-specific gynecologic oncology M&M rounds and identify reasons for hospital admission Methods: Between July 2014 and April 2016, all admissions Results: 585 patients were admitted, 78% of whom had ovarian cancer and 43% of whom had recurrent disease. Overall, 47% of admissions were unplanned and these were significantly longer than planned admissions (5.6 vs. 2.4 days, p = 0.0003). Of unplanned admissions, 43% were due to chemotherapy, and 57% were due to disease burden. 74% of patients had received >1 prior line of chemotherapy, and 22% were on clinical trial. The most common causes of unplanned admission were nausea, vomiting or failure to thrive (28.9%), fever (17.9%) and small bowel obstruction (19.9%). Conclusions: There is a high rate of unplanned admission